{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "update_type": "Revised",
      "initial_posting_date": "07/12/2022",
      "package_ndc": "0703-4636-01",
      "generic_name": "Streptozocin Powder, For Solution",
      "contact_info": "800-545-8800",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "update_date": "08/17/2026",
      "therapeutic_category": [
        "Oncology"
      ],
      "dosage_form": "Powder, For Solution",
      "presentation": "Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01)",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "shortage_reason": "Other",
      "status": "Current"
    }
  ]
}